Cargando…

Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells

The application of liposuctioned white adipose tissue (L-WAT) and adipose-derived stem cells (ADSCs) as a novel immunomodulatory treatment option is the currently subject of various clinical trials. Because it is crucial to understand the underlying therapeutic mechanisms, the latest studies focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Sara, Volkmer, Elias, Haas, Elisabeth, Alberton, Paolo, Straub, Tobias, David-Rus, Diana, Aszodi, Attila, Giunta, Riccardo, Saller, Maximilian Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037886/
https://www.ncbi.nlm.nih.gov/pubmed/32041245
http://dx.doi.org/10.3390/ijms21031086
_version_ 1783500526528233472
author Taha, Sara
Volkmer, Elias
Haas, Elisabeth
Alberton, Paolo
Straub, Tobias
David-Rus, Diana
Aszodi, Attila
Giunta, Riccardo
Saller, Maximilian Michael
author_facet Taha, Sara
Volkmer, Elias
Haas, Elisabeth
Alberton, Paolo
Straub, Tobias
David-Rus, Diana
Aszodi, Attila
Giunta, Riccardo
Saller, Maximilian Michael
author_sort Taha, Sara
collection PubMed
description The application of liposuctioned white adipose tissue (L-WAT) and adipose-derived stem cells (ADSCs) as a novel immunomodulatory treatment option is the currently subject of various clinical trials. Because it is crucial to understand the underlying therapeutic mechanisms, the latest studies focused on the immunomodulatory functions of L-WAT or ADSCs. However, studies that examine the specific transcriptional adaptation of these treatment options to an extrinsic inflammatory stimulus in an unbiased manner are scarce. The aim of this study was to compare the gene expression profile of L-WAT and ADSCs, when subjected to tumor necrosis factor alpha (TNFα), and to identify key factors that might be therapeutically relevant when using L-WAT or ADSCs as an immuno-modulator. Fat tissue was harvested by liposuction from five human donors. ADSCs were isolated from the same donors and shortly subjected to expansion culture. L-WAT and ADSCs were treated with human recombinant TNFα, to trigger a strong inflammatory response. Subsequently, an mRNA deep next-generation sequencing was performed to evaluate the different inflammatory responses of L-WAT and ADSCs. We found significant gene expression changes in both experimental groups after TNFα incubation. However, ADSCs showed a more homogenous gene expression profile by predominantly expressing genes involved in immunomodulatory processes such as CCL19, CCL5, TNFSF15 and IL1b when compared to L-WAT, which reacted rather heterogeneously. As RNA sequencing between L-WAT and ADSCS treated with TNFα revealed that L-WAT responded very heterogeneously to TNFα treatment, we therefore conclude that ADSCs are more reliable and predictable when used therapeutically. Our study furthermore yields insight into potential biological processes regarding immune system response, inflammatory response, and cell activation. Our results can help to better understand the different immunomodulatory effects of L-WAT and ADSCs.
format Online
Article
Text
id pubmed-7037886
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70378862020-03-10 Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells Taha, Sara Volkmer, Elias Haas, Elisabeth Alberton, Paolo Straub, Tobias David-Rus, Diana Aszodi, Attila Giunta, Riccardo Saller, Maximilian Michael Int J Mol Sci Article The application of liposuctioned white adipose tissue (L-WAT) and adipose-derived stem cells (ADSCs) as a novel immunomodulatory treatment option is the currently subject of various clinical trials. Because it is crucial to understand the underlying therapeutic mechanisms, the latest studies focused on the immunomodulatory functions of L-WAT or ADSCs. However, studies that examine the specific transcriptional adaptation of these treatment options to an extrinsic inflammatory stimulus in an unbiased manner are scarce. The aim of this study was to compare the gene expression profile of L-WAT and ADSCs, when subjected to tumor necrosis factor alpha (TNFα), and to identify key factors that might be therapeutically relevant when using L-WAT or ADSCs as an immuno-modulator. Fat tissue was harvested by liposuction from five human donors. ADSCs were isolated from the same donors and shortly subjected to expansion culture. L-WAT and ADSCs were treated with human recombinant TNFα, to trigger a strong inflammatory response. Subsequently, an mRNA deep next-generation sequencing was performed to evaluate the different inflammatory responses of L-WAT and ADSCs. We found significant gene expression changes in both experimental groups after TNFα incubation. However, ADSCs showed a more homogenous gene expression profile by predominantly expressing genes involved in immunomodulatory processes such as CCL19, CCL5, TNFSF15 and IL1b when compared to L-WAT, which reacted rather heterogeneously. As RNA sequencing between L-WAT and ADSCS treated with TNFα revealed that L-WAT responded very heterogeneously to TNFα treatment, we therefore conclude that ADSCs are more reliable and predictable when used therapeutically. Our study furthermore yields insight into potential biological processes regarding immune system response, inflammatory response, and cell activation. Our results can help to better understand the different immunomodulatory effects of L-WAT and ADSCs. MDPI 2020-02-06 /pmc/articles/PMC7037886/ /pubmed/32041245 http://dx.doi.org/10.3390/ijms21031086 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Taha, Sara
Volkmer, Elias
Haas, Elisabeth
Alberton, Paolo
Straub, Tobias
David-Rus, Diana
Aszodi, Attila
Giunta, Riccardo
Saller, Maximilian Michael
Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title_full Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title_fullStr Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title_full_unstemmed Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title_short Differences in the Inflammatory Response of White Adipose Tissue and Adipose-Derived Stem Cells
title_sort differences in the inflammatory response of white adipose tissue and adipose-derived stem cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037886/
https://www.ncbi.nlm.nih.gov/pubmed/32041245
http://dx.doi.org/10.3390/ijms21031086
work_keys_str_mv AT tahasara differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT volkmerelias differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT haaselisabeth differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT albertonpaolo differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT straubtobias differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT davidrusdiana differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT aszodiattila differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT giuntariccardo differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells
AT sallermaximilianmichael differencesintheinflammatoryresponseofwhiteadiposetissueandadiposederivedstemcells